Prevalence of Alcohol-Interactive Prescription Medication Use Among Current Drinkers: United States, 1999 to 2010

Rosalind A. Breslow, Chuanhui Dong, Aaron White

Research output: Contribution to journalArticle

40 Citations (Scopus)

Abstract

Background: The majority of Americans consume alcoholic beverages. Alcohol interacts negatively with numerous commonly prescribed medications. Yet, on a population level, little is known about use of alcohol-interactive (AI) prescription medications among drinkers. The purpose of our study was to determine the prevalence of AI prescription medication use among current drinkers in the U.S. population. Methods: Data were from the National Health and Nutrition Examination Survey (NHANES 1999 to 2010); 26,657 adults aged ≥20 years had data on past year alcohol consumption and past month prescription medication use. Analyses were adjusted for covariates: age, race/ethnicity, education, marital status, and smoking. Statistical procedures accounted for survey stratification, clustering, and nonresponse. Analyses were weighted to be nationally representative. Results: The unadjusted total prevalence of AI medication use was 42.8% (95% confidence interval [CI] 41.5 to 44.0). Among current drinkers, adjusted prevalence was 41.5% (CI 40.3 to 42.7). Among participants aged ≥65 total prevalence of AI medication use was 78.6% (CI 77.3 to 79.9) and adjusted prevalence among current drinkers was 77.8% (CI 75.7 to 79.7). The AI medications most commonly used by current drinkers were cardiovascular agents, central nervous system agents, and metabolic agents. Conclusions: Our results suggest that there could be substantial simultaneous exposure to alcohol and AI prescription medications in the U.S. population. Given the adverse health risks of combining alcohol with AI prescription medications, future efforts are needed to collect data to determine actual simultaneous prevalence.

Original languageEnglish
Pages (from-to)371-379
Number of pages9
JournalAlcoholism: Clinical and Experimental Research
Volume39
Issue number2
DOIs
StatePublished - Feb 1 2015
Externally publishedYes

Fingerprint

Prescriptions
Alcohols
Confidence Intervals
Nutrition Surveys
Central Nervous System Agents
Population
Cardiovascular Agents
Alcoholic Beverages
Marital Status
Health risks
Alcohol Drinking
Nutrition
Cluster Analysis
Smoking
Education
Health

Keywords

  • Alcohol Consumption
  • Cross-Sectional Survey
  • Drinking Behavior
  • Drinking Patterns
  • Drugs
  • Medications
  • National Health and Nutrition Examination Survey
  • Prescription Medications

ASJC Scopus subject areas

  • Medicine (miscellaneous)
  • Psychiatry and Mental health
  • Toxicology

Cite this

Prevalence of Alcohol-Interactive Prescription Medication Use Among Current Drinkers : United States, 1999 to 2010. / Breslow, Rosalind A.; Dong, Chuanhui; White, Aaron.

In: Alcoholism: Clinical and Experimental Research, Vol. 39, No. 2, 01.02.2015, p. 371-379.

Research output: Contribution to journalArticle

@article{07a02a525f3f453b899d72b75b377707,
title = "Prevalence of Alcohol-Interactive Prescription Medication Use Among Current Drinkers: United States, 1999 to 2010",
abstract = "Background: The majority of Americans consume alcoholic beverages. Alcohol interacts negatively with numerous commonly prescribed medications. Yet, on a population level, little is known about use of alcohol-interactive (AI) prescription medications among drinkers. The purpose of our study was to determine the prevalence of AI prescription medication use among current drinkers in the U.S. population. Methods: Data were from the National Health and Nutrition Examination Survey (NHANES 1999 to 2010); 26,657 adults aged ≥20 years had data on past year alcohol consumption and past month prescription medication use. Analyses were adjusted for covariates: age, race/ethnicity, education, marital status, and smoking. Statistical procedures accounted for survey stratification, clustering, and nonresponse. Analyses were weighted to be nationally representative. Results: The unadjusted total prevalence of AI medication use was 42.8{\%} (95{\%} confidence interval [CI] 41.5 to 44.0). Among current drinkers, adjusted prevalence was 41.5{\%} (CI 40.3 to 42.7). Among participants aged ≥65 total prevalence of AI medication use was 78.6{\%} (CI 77.3 to 79.9) and adjusted prevalence among current drinkers was 77.8{\%} (CI 75.7 to 79.7). The AI medications most commonly used by current drinkers were cardiovascular agents, central nervous system agents, and metabolic agents. Conclusions: Our results suggest that there could be substantial simultaneous exposure to alcohol and AI prescription medications in the U.S. population. Given the adverse health risks of combining alcohol with AI prescription medications, future efforts are needed to collect data to determine actual simultaneous prevalence.",
keywords = "Alcohol Consumption, Cross-Sectional Survey, Drinking Behavior, Drinking Patterns, Drugs, Medications, National Health and Nutrition Examination Survey, Prescription Medications",
author = "Breslow, {Rosalind A.} and Chuanhui Dong and Aaron White",
year = "2015",
month = "2",
day = "1",
doi = "10.1111/acer.12633",
language = "English",
volume = "39",
pages = "371--379",
journal = "Alcoholism: Clinical and Experimental Research",
issn = "0145-6008",
publisher = "Wiley-Blackwell",
number = "2",

}

TY - JOUR

T1 - Prevalence of Alcohol-Interactive Prescription Medication Use Among Current Drinkers

T2 - United States, 1999 to 2010

AU - Breslow, Rosalind A.

AU - Dong, Chuanhui

AU - White, Aaron

PY - 2015/2/1

Y1 - 2015/2/1

N2 - Background: The majority of Americans consume alcoholic beverages. Alcohol interacts negatively with numerous commonly prescribed medications. Yet, on a population level, little is known about use of alcohol-interactive (AI) prescription medications among drinkers. The purpose of our study was to determine the prevalence of AI prescription medication use among current drinkers in the U.S. population. Methods: Data were from the National Health and Nutrition Examination Survey (NHANES 1999 to 2010); 26,657 adults aged ≥20 years had data on past year alcohol consumption and past month prescription medication use. Analyses were adjusted for covariates: age, race/ethnicity, education, marital status, and smoking. Statistical procedures accounted for survey stratification, clustering, and nonresponse. Analyses were weighted to be nationally representative. Results: The unadjusted total prevalence of AI medication use was 42.8% (95% confidence interval [CI] 41.5 to 44.0). Among current drinkers, adjusted prevalence was 41.5% (CI 40.3 to 42.7). Among participants aged ≥65 total prevalence of AI medication use was 78.6% (CI 77.3 to 79.9) and adjusted prevalence among current drinkers was 77.8% (CI 75.7 to 79.7). The AI medications most commonly used by current drinkers were cardiovascular agents, central nervous system agents, and metabolic agents. Conclusions: Our results suggest that there could be substantial simultaneous exposure to alcohol and AI prescription medications in the U.S. population. Given the adverse health risks of combining alcohol with AI prescription medications, future efforts are needed to collect data to determine actual simultaneous prevalence.

AB - Background: The majority of Americans consume alcoholic beverages. Alcohol interacts negatively with numerous commonly prescribed medications. Yet, on a population level, little is known about use of alcohol-interactive (AI) prescription medications among drinkers. The purpose of our study was to determine the prevalence of AI prescription medication use among current drinkers in the U.S. population. Methods: Data were from the National Health and Nutrition Examination Survey (NHANES 1999 to 2010); 26,657 adults aged ≥20 years had data on past year alcohol consumption and past month prescription medication use. Analyses were adjusted for covariates: age, race/ethnicity, education, marital status, and smoking. Statistical procedures accounted for survey stratification, clustering, and nonresponse. Analyses were weighted to be nationally representative. Results: The unadjusted total prevalence of AI medication use was 42.8% (95% confidence interval [CI] 41.5 to 44.0). Among current drinkers, adjusted prevalence was 41.5% (CI 40.3 to 42.7). Among participants aged ≥65 total prevalence of AI medication use was 78.6% (CI 77.3 to 79.9) and adjusted prevalence among current drinkers was 77.8% (CI 75.7 to 79.7). The AI medications most commonly used by current drinkers were cardiovascular agents, central nervous system agents, and metabolic agents. Conclusions: Our results suggest that there could be substantial simultaneous exposure to alcohol and AI prescription medications in the U.S. population. Given the adverse health risks of combining alcohol with AI prescription medications, future efforts are needed to collect data to determine actual simultaneous prevalence.

KW - Alcohol Consumption

KW - Cross-Sectional Survey

KW - Drinking Behavior

KW - Drinking Patterns

KW - Drugs

KW - Medications

KW - National Health and Nutrition Examination Survey

KW - Prescription Medications

UR - http://www.scopus.com/inward/record.url?scp=84922826264&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84922826264&partnerID=8YFLogxK

U2 - 10.1111/acer.12633

DO - 10.1111/acer.12633

M3 - Article

C2 - 25597432

AN - SCOPUS:84922826264

VL - 39

SP - 371

EP - 379

JO - Alcoholism: Clinical and Experimental Research

JF - Alcoholism: Clinical and Experimental Research

SN - 0145-6008

IS - 2

ER -